Have a personal or library account? Click to login

Case Report for Two Siblings Carrying Neurofibromatosis Type 1 with a Rare NF1: c.5392C>T Mutation

Open Access
|Jun 2022

References

  1. Friedman JM. Neurofibromatosis 1. GeneReviews®. Adam MP, Ardinger HH, Pagon RA, et al., Editors. Seattle, WA, USA: University of Washington, Seattle; 1993–2021. [Accessed July 2021] Available at: https://www.ncbi.nlm.nih.gov/books/NBK1109/.
  2. Lammert M, Friedman JM, Kluwe L, Mautner VF. Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol. 2005; 141(1): 71–74.
  3. Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, et al. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A. 2010; 152A(2): 327–332.
  4. Yang F, Xu S, Liu R, Shi T, Li X, Li X, et al. The investigation for potential modifier genes in patients with neurofibromatosis type 1 based on next-generation sequencing. Onco Targets Ther. 2018; 11: 919–932.
  5. Shen MH, Harper PS, Upadhyaya M. Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet. 1996; 33(1): 2–17.
  6. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al.; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5): 405–424.
  7. Anastasaki C, Le LQ, Kesterson RA, Gutmann DH. Updated nomenclature for human and mouse neurofibromatosis type 1 genes. Neurol Genet. 2017; 3(4): e169.
  8. Cooper DN, Ball EV, Stenson PD, Phillips AD, Evans K, Heywood S, et al. The human gene mutation database at the Institute of Medical Genetics in Cardiff. [Accessed February 2021] Available at: http://www.hgmd.cf.ac.uk/ac/gene.php?gene=NF1).
  9. Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Albarca Aguilera M, Meyer R, et al. VarSome: The Human Genomic Variant Search Engine. Bioinformatics. 2019; 35(11): 1978–1980. doi: 10.1093/bioinformatics/bty897.bty897. [Accessed October 2018].
  10. Zhu G, Zheng Y, Liu Y, Yan A, Hu Z, Yang Y, et al. Identification and characterization of NF1 and no-NF1 congenital pseudoarthrosis of the tibia based on germline NF1 variants: Genetic and clinical analysis of 75 patients. Orphanet J Rare Dis. 2019; 14(1): 221.
  11. Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer. 1986; 57(10): 2006–2021.
  12. Sharafi P, Ayter S. Possible modifier genes in the variation of neurofibromatosis type 1 clinical phenotypes. J Neurogenet. 2018; 32(2): 65–77.
  13. Pasmant E, Vidaud M, Vidaud D, Wolkenstein P. Neurofibromatosis type 1: From genotype to phenotype. J Med Genet. 2012;49(8): 483–489.
Language: English
Page range: 99 - 102
Published on: Jun 5, 2022
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2022 DB Sayın Kocakap, Ö Gündüz, L Özer, M Durak, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.